Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials
- PMID: 32384902
- PMCID: PMC7206824
- DOI: 10.1186/s12944-020-01214-w
Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials
Abstract
Background: Previous studies have yielded inconsistent findings on the role of fish oil in type 2 diabetes mellitus (T2DM). We systematically summarized the available evidence from randomized controlled trials (RCT) and aimed to investigate the effects of fish oil supplementation on glucose control and lipid levels among patients with T2DM.
Methods: A comprehensive literature search was performed in electronic databases (PubMed, ProQuest, Cochrane Library, CNKI, VIP, and Wanfang) to identify all relevant RCTs which were published up to May 31st, 2019. We used Modified Jadad Score system to evaluate the quality of each included RCT. The pooled effects were estimated using random-effects model and presented as standardized mean differences with 95% confidence intervals.
Results: A total of 12 RCTs were included in this meta-analysis. There was no significant difference in glucose control outcomes comparing fish oil supplementation to placebo. The effect size of fasting plasma glucose (FPG) was 0.13 (95% CI: - 0.03 to 0.28, p > 0.05). No marked change was observed in fasting insulin (FINS), glycosylated hemoglobin (HbA1c), and HOMA of insulin resistance (HOMA-IR) levels. Fish oil supplementation was associated with a decrease of triglyceride (TG) level by - 0.40 (95%CI: - 0.53 to - 0.28, p < 0.05), and an increase of high density lipoprotein (HDL) cholesterol level by 0.21 (95%CI: 0.05 to 0.37, p < 0.05). In subgroup analysis, HDL cholesterol level was higher among Asian and low-dose(< 2 g/d n-3 PUFA) subgroups compared to their counterparts (p < 0.05). TG level was lower in mid and long duration groups, along with an inconspicuous difference in short duration group.
Conclusions: This meta-analysis shows that among patients with T2DM, fish oil supplementation leads to a favorable blood lipids profile but does not improve glucose control.
Keywords: Fish oil; Meta-analysis; Omega-3 fatty acids; Randomized clinical trials; Type 2 diabetes mellitus.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.Diabetes. 1989 Oct;38(10):1314-9. doi: 10.2337/diab.38.10.1314. Diabetes. 1989. PMID: 2676659 Clinical Trial.
-
Effect of fish oil concentrate on lipoprotein composition in NIDDM.Diabetes. 1988 Nov;37(11):1567-73. doi: 10.2337/diab.37.11.1567. Diabetes. 1988. PMID: 3181646 Clinical Trial.
-
Effects of whey protein on glycemic control and serum lipoproteins in patients with metabolic syndrome and related conditions: a systematic review and meta-analysis of randomized controlled clinical trials.Lipids Health Dis. 2020 Sep 21;19(1):209. doi: 10.1186/s12944-020-01384-7. Lipids Health Dis. 2020. PMID: 32958070 Free PMC article.
-
A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes.Diabetes Care. 1996 May;19(5):463-7. doi: 10.2337/diacare.19.5.463. Diabetes Care. 1996. PMID: 8732710 Clinical Trial.
-
Effects of high-protein diet on glycemic control, insulin resistance and blood pressure in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.Clin Nutr. 2020 Jun;39(6):1724-1734. doi: 10.1016/j.clnu.2019.08.008. Epub 2019 Aug 15. Clin Nutr. 2020. PMID: 31466731
Cited by
-
Effects of Fish Oil Supplementation on Cardiometabolic Risk Factors in Overweight or Obese Children and Adolescents: A Meta-Analysis of Randomized Controlled Trials.Front Pediatr. 2021 Apr 27;9:604469. doi: 10.3389/fped.2021.604469. eCollection 2021. Front Pediatr. 2021. PMID: 33987149 Free PMC article.
-
Processing Alaska Pollock Protein (Theragra chalcogramma) into Kamaboko Protein Mitigates Elevated Serum Cholesterol and Postprandial Glucose Levels in Obese Zucker fa/fa Rats.Foods. 2022 Oct 29;11(21):3434. doi: 10.3390/foods11213434. Foods. 2022. PMID: 36360046 Free PMC article.
-
Reduction of cardiovascular risk factors by the diet - Evaluation of the MoKaRi concept by a parallel-designed randomized study.Lipids Health Dis. 2025 Mar 8;24(1):88. doi: 10.1186/s12944-025-02500-1. Lipids Health Dis. 2025. PMID: 40057729 Free PMC article. Clinical Trial.
-
Impact of α-Linolenic Acid, the Vegetable ω-3 Fatty Acid, on Cardiovascular Disease and Cognition.Adv Nutr. 2022 Oct 2;13(5):1584-1602. doi: 10.1093/advances/nmac016. Adv Nutr. 2022. PMID: 35170723 Free PMC article.
-
Effect of n-3 (Omega-3) Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers and Body Weight in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of RCTs.Metabolites. 2021 Oct 28;11(11):742. doi: 10.3390/metabo11110742. Metabolites. 2021. PMID: 34822400 Free PMC article.
References
-
- World Health Organization. World Health Organization (2016) Global Report on Diabetes. 2016. p. 20–31.
-
- Afshin A, Sur PJ, Fay KA, Cornaby L, Ferrara G, Salama JS, Mullany EC, Abate KH, Abbafati C, Abebe Z, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019;393(10184):1958–1972. doi: 10.1016/S0140-6736(19)30041-8. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous